Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 05, 2020
Qualigen has signed a contract with WuXi STA for GMP production of AS1411, Qualigen's lead drug candidate for the treatment of COVID-19 and other viral diseases, for potential clinical trials.
read more
Friday, November 06, 2020
Flamma has entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury (remdesivir) supply chain.
read more
Tuesday, November 10, 2020
Novasep is investing €6.5 million to expand capacity & increase flexibility in an API manufacturing workshop at its Chasse-sur-Rhône site.
read more
Tuesday, November 10, 2020
Thermo Fisher Scientific and Innoforce have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China.
read more
Wednesday, November 11, 2020
Centogene and Fujirebio Europe have entered a partnership to leverage LUMIPULSE G technology for large-scale COVID-19 antigen testing with further deployment in German airports.
read more
Friday, November 13, 2020
Flamma entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury supply chain.
read more
Monday, November 16, 2020
Moderna announced the DSMB for the Phase 3 study of mRNA-1273 has informed the company the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%.
read more
Monday, November 16, 2020
TCR2 Therapeutics has established a manufacturing partnership with ElevateBio, to leverage the technical capabilities at ElevateBio BaseCamp, a cell and gene therapy manufacturing facility based in Waltham, MA.
read more
Monday, November 16, 2020
Pharmaron Beijing has acquired 100% of the equity of Absorption Systems for up to US$137.5 million in cash.
read more
Wednesday, November 18, 2020
Stelis BioSource has started the next phase of its continued investment program.
read more
Monday, November 23, 2020
Onyx Scientific announced it is investing in a new facility at its UK site in order to prepare for the approval of a commercial API license.
read more
Monday, November 23, 2020
CCRM and MIP have signed a LOI to partner in the development of a biomanufacturing campus at MIP focused on regenerative medicine-based technologies and cell and gene therapies.
read more
Tuesday, November 24, 2020
Samsung Biologics' partnership with Eli Lilly and Company is expected to accelerate the global supply for Lilly's COVID-19 antibody therapies through a long-term manufacturing agreement.
read more
Wednesday, November 25, 2020
Bionova Scientific announced it has secured its first client commitment for GMP clinical supply.
read more
Wednesday, November 25, 2020
Cambrex is expanding its mid-scale and large-scale API manufacturing capacity in Charles City, Iowa.
read more